πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7906292

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epito

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7897152

Viral chemokine-antigen fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7888070

Nucleic acids encoding growth hormone with a modified RSP sorting signal

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7888069

Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences

The United States of America as represented by the Secretary of Argriculture Β· Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7867983

Methods to protect skeletal muscle against injury

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7863041

Rabies virus vector systems and compositions and methods thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7851169

Compositions and methods for inhibiting squamous cell carcinoma

The United States of America as represented by the Department of Veterans Affairs Office of the General Counsel Β· Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7825154

Small molecule inhibitors of botulinum neurotoxins

The United States of America as represented by the Secretary of the Army Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807458

Multilineage-inducible cells and uses thereof

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7803386

Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790186

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790181

Live attenuated viral vaccines for Eastern Equine Encephalitis virus

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790182

Protein vaccines against poxviruses

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7786285

Recombinant vaccine against botulinum neurotoxin

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7780966

Artificial invaplex

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7776521

Coronavirus isolated from humans

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7759106

Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7754461

Large-scale production of human serum butyrylcholinesterase as a bioscavenger

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7741431

Liposomes containing novel targeting and/or fusogenic peptides, preparations containing th

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 22 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7736656

Immunogenic compositions and vaccines for Ebola

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7731971

Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7731975

Chimeric filovirus glycoprotein

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7722889

Plasmodium liver stage antigens

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7718779

Prophylactic and therapeutic monoclonal antibodies

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted